AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie adjusted Effective Tax Rate — Non-GAAP (%) (%)
Form 8-K Non-GAAP Reconciliations
Latest, FY2025
18.0%
Period ended Dec 31, 2025
Change on a year earlier
+0.6 pts
17.4% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Adjusted Effective Tax Rate — Non-GAAP (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.0% | +0.6 pts | Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 17.4% | +1.7 pts | Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗ |
| FY2023 | Dec 31, 2023 | 15.7% | +2.7 pts | Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗ |
| FY2022 | Dec 31, 2022 | 13.0% | – | Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗ |
Breakdown
What makes up adjusted effective tax rate — non-gaap (%)
Cite this data
StockData. (2026). AbbVie Adjusted Effective Tax Rate — Non-GAAP (%) (%), annual FY2022–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/nongaap_adj_tax_rate
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.